» Articles » PMID: 36552858

TRIP13 Participates in Immediate-Early Sensing of DNA Strand Breaks and ATM Signaling Amplification Through MRE11

Abstract

Thyroid hormone receptor-interacting protein 13 (TRIP13) participates in various regulatory steps related to the cell cycle, such as the mitotic spindle assembly checkpoint and meiotic recombination, possibly by interacting with members of the HORMA domain protein family. Recently, it was reported that TRIP13 could regulate the choice of the DNA repair pathway, i.e., homologous recombination (HR) or nonhomologous end-joining (NHEJ). However, TRIP13 is recruited to DNA damage sites within a few seconds after damage and may therefore have another function in DNA repair other than regulation of the pathway choice. Furthermore, the depletion of TRIP13 inhibited both HR and NHEJ, suggesting that TRIP13 plays other roles besides regulation of choice between HR and NHEJ. To explore the unidentified functions of TRIP13 in the DNA damage response, we investigated its genome-wide interaction partners in the context of DNA damage using quantitative proteomics with proximity labeling. We identified MRE11 as a novel interacting partner of TRIP13. TRIP13 controlled the recruitment of MDC1 to DNA damage sites by regulating the interaction between MDC1 and the MRN complex. Consistently, TRIP13 was involved in ATM signaling amplification. Our study provides new insight into the function of TRIP13 in immediate-early DNA damage sensing and ATM signaling activation.

Citing Articles

TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress.

Anand J, Droby G, Joseph S, Patel U, Zhang X, Klomp J bioRxiv. 2025; .

PMID: 39975297 PMC: 11838190. DOI: 10.1101/2025.01.26.634889.


Repeated ionizing radiation exposure induces TRIP13 expression, conferring radioresistance in lung cancer cells.

Liu W, Lei Q, van Pelt A, Hamer G Sci Rep. 2025; 15(1):985.

PMID: 39762328 PMC: 11704074. DOI: 10.1038/s41598-024-84592-w.


Genome-Wide Methylation Profiling of Peripheral T-Cell Lymphomas Identifies TRIP13 as a Critical Driver of Tumor Proliferation and Survival.

Nowialis P, Tobon J, Lopusna K, Opavska J, Badar A, Chen D Epigenomes. 2024; 8(3).

PMID: 39189258 PMC: 11348144. DOI: 10.3390/epigenomes8030032.


Mosaic variegated aneuploidy in development, ageing and cancer.

Malumbres M, Villarroya-Beltri C Nat Rev Genet. 2024; 25(12):864-878.

PMID: 39169218 DOI: 10.1038/s41576-024-00762-6.


Genome-wide methylation profiling of Peripheral T-cell lymphomas identifies TRIP13 as a critical driver of tumor proliferation and survival.

Nowialis P, Tobon J, Lopusna K, Opavska J, Badar A, Chen D Res Sq. 2024; .

PMID: 38464090 PMC: 10925438. DOI: 10.21203/rs.3.rs-3971059/v1.


References
1.
Howard S, Yanez D, Stark J . DNA damage response factors from diverse pathways, including DNA crosslink repair, mediate alternative end joining. PLoS Genet. 2015; 11(1):e1004943. PMC: 4309583. DOI: 10.1371/journal.pgen.1004943. View

2.
Munoz I, Jowsey P, Toth R, Rouse J . Phospho-epitope binding by the BRCT domains of hPTIP controls multiple aspects of the cellular response to DNA damage. Nucleic Acids Res. 2007; 35(16):5312-22. PMC: 2018624. DOI: 10.1093/nar/gkm493. View

3.
Drew K, Wallingford J, Marcotte E . hu.MAP 2.0: integration of over 15,000 proteomic experiments builds a global compendium of human multiprotein assemblies. Mol Syst Biol. 2021; 17(5):e10016. PMC: 8111494. DOI: 10.15252/msb.202010016. View

4.
Stucki M, Clapperton J, Mohammad D, Yaffe M, Smerdon S, Jackson S . MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell. 2005; 123(7):1213-26. DOI: 10.1016/j.cell.2005.09.038. View

5.
Boersma V, Moatti N, Segura-Bayona S, Peuscher M, van der Torre J, Wevers B . MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5' end resection. Nature. 2015; 521(7553):537-540. PMC: 4481296. DOI: 10.1038/nature14216. View